Fertility and Sterility
Volume 91, Issue 5 , Pages 1919-1925 , May 2009

Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro

  • Merja Bläuer, Ph.D.

      Affiliations

    • Department of Cell Biology, University of Tampere, Tampere, Finland
    • ,
  • Päivi H. Rovio, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland
    • Corresponding Author InformationReprint requests: Päivi H. Rovio, M.D., Department of Obstetrics and Gynecology, Tampere University Hospital, FI-33521, Tampere, Finland (FAX: +358 3 311 64360).
    • ,
  • Timo Ylikomi, M.D.

      Affiliations

    • Department of Cell Biology, University of Tampere, Tampere, Finland
    • ,
  • Pentti K. Heinonen, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland
    • Medical School, University of Tampere, Tampere, Finland

Received 6 November 2007 ,Revised 20 February 2008 ,Accepted 20 February 2008.

References 

  1. Stewart EA. Uterine fibroids. Lancet. 2001;357:293–298
  2. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol. 2002;99:229–234
  3. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111:1037–1054
  4. Arslan AA, Gold LI, Mital K, Suen TC, Belitskaya-Levy I, Tang MS, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005;20:852–863
  5. Shushan A, Ben-Bassat H, Mishani E, Laufer N, Klein BY, Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertil Steril. 2007;87:127–135
  6. McDonnel DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science. 1987;235:1214–1217
  7. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA. 1988;85:3294–3298
  8. Vienonen A, Miettinen S, Bläuer M, Martikainen P, Tomas E, Heinonen PK, et al. Expression of nuclear receptors and cofactors in human endometrium and myometrium. J Soc Gynecol Investig. 2004;11:104–112
  9. Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 1997;6:727–732
  10. Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, et al. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev. 1999;8:241–248
  11. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000;87:214–220
  12. Ylikomi T, Laaksi I, Lou YR, Martikainen P, Miettinen S, Pennanen P, et al. Antiproliferative action of vitamin D. Vitam Horm. 2002;64:357–406
  13. Wang QM, Jones JB, Studzinski GP. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 1996;56:264–267
  14. Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat. 1997;42:31–41
  15. Zhuang SH, Burnstein KL. Antiproliferative effect of 1 alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCap involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology. 1998;139:1197–1207
  16. Hager G, Formanek M, Gedlicka C, Thurnher D, Knerer B, Kornfehl J. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol. 2001;121:103–109
  17. Audo I, Darjatmoko SR, Schlamp CL, Lokken JM, Lindstrom MJ, Albert DM, et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci. 2003;44:4192–4199
  18. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002;9:45–49
  19. Welsh J, Simboli-Campbell M, Narvaez CJ, Tenniswood M. Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Med Biol. 1995;375:45–52
  20. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem. 1989;182:16–19
  21. Lou Y-R, Laaksi I, Syvälä H, Bläuer M, Tammela TLJ, Ylikomi T, et al. 25-Hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J. 2004;18:332–334
  22. Barreto AM, Schwarz GG, Woodruff R, Cramer SD. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev. 2000;9:265–270
  23. Itin PH, Pittelkow MR, Kumar R. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology. 1994;135:1793–1798
  24. Miettinen S, Ahonen M, Lou Y-R, Manninen T, Tuohimaa P, Syvälä H, et al. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells. Int J Cancer. 2004;108:367–373
  25. Munker R, Norman A, Koeffler HP. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest. 1986;78:424–430
  26. Love-Schimenti CD, Gibson DF, Ratnam AV, Bikle DD. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells. Cancer Res. 1996;56:2789–2794
  27. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888–894
  28. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig. 2004;5:263–271
  29. Shushan A, Rojansky N, Laufer N, Klein BY, Shlomai Z, Levitzki R, et al. The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth. Hum Reprod. 2004;19:1957–1967
  30. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem. 1986;159:109–113
  31. Palmberg L, Thyberg J. Uterine smooth muscle cells in primary culture. Alterations in fine structure, cytoskeletal organization and growth characteristics. Cell Tissue Res. 1986;246:253–262
  32. Virtanen I, Lehto V-P, Lehtonen E, Vartio T, Stenman S, Kurki P, et al. Expression of intermediate filaments in cultured cells. J Cell Sci. 1981;50:45–63
  33. Broaddus RR, Xie S, Hsu C-J, Wang J, Zhang S, Zou C. The chemopreventive agents 4-HPR snd DFMO inhibit growth and induce apoptosis in uterine leiomyomas. Am J Obstet Gynecol. 2004;190:686–692
  34. Yamada T, Nakago S, Kurachi O, Wang J, Takekida S, Matsuo H, et al. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells. Hum Reprod. 2004;19:815–821
  35. Severino MF, Murray MJ, Brandon DD, Clinton GM, Burry KA, Novy M. Rapid loss of estrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol Hum Reprod. 1996;11:823–828

 M.B. has nothing to disclose. P.H.R. has nothing to disclose. T.Y. has nothing to disclose. P.K.H. has nothing to disclose.

 Supported by grants from competitive research funding of the Pirkanmaa Hospital District, Tampere, and TEKES Drug 2000, Finland.

PII: S0015-0282(08)00500-1

doi: 10.1016/j.fertnstert.2008.02.136

Fertility and Sterility
Volume 91, Issue 5 , Pages 1919-1925 , May 2009

Article Tools

* Image Usage & Resolution